Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.16 and traded as low as $1.1101. BioRestorative Therapies shares last traded at $1.15, with a volume of 15,196 shares.
BioRestorative Therapies Stock Up 3.6%
The company has a market cap of $10.21 million, a P/E ratio of -0.78 and a beta of 0.28. The firm has a 50 day moving average of $1.16 and a 200-day moving average of $1.42.
About BioRestorative Therapies
BioRestorative Therapies, Inc (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies.
Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
